Indianapolis: Indianapolis-based pharmaceutical giant Eli Lilly has faced a setback as the European Union's drug regulator ...
Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) ...
While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...
Billed as ‘Liberation Day’, President Donald Trump has pledged to unleash a new round of tariffs on April 2 that are likely ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The details of Trump's next round of import taxes are still sketchy. Most economic analyses say average U.S. families would ...
N. Meridian leased its first apartments to renters, becoming the first office to residences conversion project of its kind in Central Indiana.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback